CLINICAL MEASUREMENT - ANNOTATIONS
The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml ).
Term: immune system measurement
Accession: CMO:0001579
browse the term
Definition: Any value resulting from the quantification of a morphological or physiological parameter of the immune system, a complex set of interconnected and interdependent cellular and molecular components having the primary functions of distinguishing self from not self and of defense against foreign organisms or substances.
Q
Cdexp1
CD45RC expression in CD8 T cells QTL 1
IDA
RGD
PMID:15322174
RGD:1302824
NCBI chr 9:1,024,537...67,509,080
Q
Cdexp2
CD45RC expression in CD8 T cells QTL 2
IDA
RGD
PMID:15322174
RGD:1302824
NCBI chr20:3,621,649...10,078,919
Q
Leukc1
Leukocyte quantity QTL 1
IDA
RGD
PMID:16151696
RGD:5135221
NCBI chr19:44,340,214...55,283,277
Q
Leukc2
Leukocyte quantity QTL 2
IDA
RGD
PMID:16151696
RGD:5135221
NCBI chr 2:118,111,229...149,559,726
Q
Leukc3
Leukocyte quantity QTL 3
IDA
RGD
PMID:17090969
RGD:5135222
NCBI chr 1:218,108,584...224,054,420
Q
Neuinf1
Neuroinflammation QTL 1
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 5:154,828,214...166,875,058
Q
Ciaa1
CIA Autoantibody QTL 1
IDA
RGD
PMID:11001927
RGD:61067
NCBI chr20:2,646,395...4,597,031
Q
Ciaa4
CIA Autoantibody QTL 4
IDA
RGD
PMID:11001927
RGD:61067
NCBI chr 4:126,395,976...167,139,601
Q
Ciaa5
CIA Autoantibody QTL 5
IDA
RGD
PMID:11001927
RGD:61067
NCBI chr 5:94,858,972...143,070,159
Q
Ciaa2
CIA Autoantibody QTL 2
IDA
RGD
PMID:10857786
RGD:61066
NCBI chr10:63,221,094...107,211,142
Q
Ciaa3
CIA Autoantibody QTL 3
IDA
RGD
PMID:10857786
RGD:61066
NCBI chr 9:7,954,720...22,071,169
Q
Ean2
Experimental allergic neuritis QTL 2
IDA
RGD
PMID:19299744
RGD:2306769
NCBI chr 4:83,428,419...95,853,334
Q
Ean4
Experimental allergic neuritis QTL 4
IDA
RGD
PMID:19299744
RGD:2306769
NCBI chr10:84,022,321...93,995,963
Q
Ean5
Experimental allergic neuritis QTL 5
IDA
RGD
PMID:19299744
RGD:2306769
NCBI chr10:72,552,416...93,995,749
Q
Nka1
Natural killer alloreactivity QTL 1
IDA
RGD
PMID:8642329
RGD:61085
Q
Neudeg2
Neurodegradation QTL 2
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 5:24,838,710...44,045,280
Q
Iresp1
Immunoglobin response QTL1
IDA
RGD
PMID:10898507
RGD:619646
NCBI chr20:9,039,719...13,461,775
Q
Iresp2
Immunoglobin response QTL2
IDA
RGD
PMID:10898507
RGD:619646
NCBI chr10:22,918,268...36,400,810
Q
Iresp3
Immunoglobin response QTL3
IDA
RGD
PMID:10898507
RGD:619646
NCBI chr 9:2,745,799...5,857,951
Q
Pia33
Pristane induced arthritis QTL 33
IDA
RGD
PMID:14674011
RGD:2302026
Q
Pia28
Pristane induced arthritis QTL 28
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr 4:73,630,210...118,630,210
Q
Pia32
Pristane induced arthritis QTL 32
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr 4:105,789,505...150,789,505
Q
Pia34
Pristane induced arthritis QTL 34
IDA
RGD
PMID:14674011
RGD:2302026
Q
Pia35
Pristane induced arthritis QTL 35
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr 1:216,255,568...260,522,016
Q
Pia36
Pristane induced arthritis QTL 36
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr 1:43,333,002...88,333,002
Q
Pia37
Pristane induced arthritis QTL 37
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr12:13,198,157...46,669,029
Q
Pia38
Pristane induced arthritis QTL 38
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr12:1...44,503,507
Q
Pia39
Pristane induced arthritis QTL 39
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr14:8,267,090...53,267,090
Q
Pia27
Pristane induced arthritis QTL 27
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr11:82,566,545...83,440,803
Q
Pia29
Pristane induced arthritis QTL 29
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr16:21,735,975...66,735,975
Q
Pia30
Pristane induced arthritis QTL 30
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr 3:27,936,919...72,936,919
Q
Pia31
Pristane induced arthritis QTL 31
IDA
RGD
PMID:14674011
RGD:2302026
NCBI chr 1:10,992,065...55,992,065
Q
Thym1
Thymus enlargement QTL 1
IDA
RGD
PMID:10792781
RGD:70859
NCBI chr 1:136,829,932...181,829,932
Q
Thym2
Thymus enlargement QTL 2
IDA
RGD
PMID:8672128
RGD:634747
NCBI chr13:46,197,976...84,753,113
Q
Thym3
Thymus enlargement QTL 3
IDA
RGD
PMID:10792781
RGD:70859
NCBI chr 1:136,829,932...181,829,932
Q
Thym4
Thymus enlargement QTL 4
IDA
RGD
PMID:10792781
RGD:70859
NCBI chr 1:197,814,409...242,814,409
Q
Tsu1
Thymus enlargement suppressive QTL 1
IDA
RGD
PMID:9234381
RGD:634729
NCBI chr 3:50,437,504...115,638,231
Q
Esta1
Estrogen-induced thymic atrophy QTL 1
IDA
RGD
PMID:16688534
RGD:1579780
NCBI chr10:21,329,805...61,345,413
Q
Esta2
Estrogen-induced thymic atrophy QTL 2
IDA
RGD
PMID:16688534
RGD:1579780
NCBI chr 2:189,599,258...226,936,289
Q
Esta3
Estrogen-induced thymic atrophy QTL 3
IDA
RGD
PMID:16688534
RGD:1579780
NCBI chr 2:136,916,935...189,599,348
Q
Esta4
Estrogen-induced thymic atrophy QTL 4
IDA
RGD
PMID:18420736
RGD:2292503
NCBI chr 3:47,233,211...147,415,807
Q
Stresp18
Stress response QTL 18
IDA
RGD
PMID:16151695
RGD:1549862
NCBI chr 5:27,955,440...72,955,440
Q
Stresp21
Stress response QTL 21
IDA
RGD
PMID:16151695
RGD:1549862
NCBI chr10:6,375,746...51,375,746
Q
Stresp22
Stress response QTL 22
IDA
RGD
PMID:16151695
RGD:1549862
NCBI chr16:35,288,870...80,288,870
Q
Wbc1
White blood cell count QTL 1
IDA
RGD
PMID:14532335
RGD:727992
NCBI chr 5:125,392,826...139,989,768
Q
Wbc2
White blood cell count QTL 2
IDA
RGD
PMID:11721057
RGD:70849
NCBI chr12:24,234,777...31,894,213
Q
Wbc3
White blood cell count QTL 3
IDA
RGD
PMID:19526527
RGD:2316974
NCBI chr 5:105,999,803...150,999,803
Q
Wbc4
White blood cell count QTL 4
IDA
RGD
PMID:19526527
RGD:2316974
NCBI chr 7:1...35,342,956
Q
Wbc5
White blood cell count QTL 5
IDA
RGD
PMID:19526527
RGD:2316974
NCBI chr 8:8,736,635...53,736,635
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all